Toggle light / dark theme

In the fictional links he drew between immortal vampires and bats, Dracula creator Bram Stoker may have had one thing right.

“Maybe it’s all in the blood,” says Emma Teeling, a geneticist studying the exceptional longevity of bats in the hope of discovering benefits for humans.

The University College Dublin researcher works with the charity Bretagne Vivante to study bats living in rural churches and schools in Brittany, western France.

Studying Novel Plasma Fractions For Age-Related Diseases And Systemic Rejuvenation — Dr. Harold Katcher Ph.D., Chief Scientific Officer, Yuvan Research Inc.


Dr. Harold Katcher is the Chief Scientific Officer at Yuvan Research Inc., a biotech company exploring the development of novel, young plasma fraction rejuvenation treatments in mammals.

Most recently Dr. Katcher was the Academic Director for Natural Sciences for the Asian Division of the University of Maryland Global Campus and throughout his career, Dr. Katcher has been a pioneer in the field of cancer research, and in the development of modern aspects of gene hunting and sequencing (including as one of the discoverers of the breast cancer gene BRCA1) as part of Myriad Genetics, and carries expertise in bioinformatics, chronobiology, and biotechnology.

The mRNA vaccine success story is one of the few positives to emerge from COVID-19. But these vaccines from Moderna and Pfizer/BioNTech are only the tip of the iceberg in the coming RNA medical technology revolution.

Australia, including our newly established UNSW RNA Institute, is well-placed to take a leading role in this revolution. With its eyes firmly set on making NSW a global force in the RNA industry, the NSW Government is backing a new RNA Bioscience Alliance between all the NSW Universities as well as funding a $15 million RNA production network between some of the state’s leading research organizations to bootstrap pre-clinical RNA research. UNSW’s RNA Institute is a key part of this drive, and with a $25 million investment brings together world-leading expertise to support the state and national agenda.

So beyond mRNA vaccines, what are these RNA therapeutics on the horizon? And what is the secret sauce that finally got mRNA vaccines to work after many years of trying? To understand this, let’s first tackle what RNA is and how it is used in medicine.

“These data suggest that differences in the microbiota following antibiotics in early life can reprogram the immune system long-term, with the consequences of this reprogramming emerging later in life, including effects on immunity, metabolism and even lifespan,” Prof Lynn said.


A team of researchers from SAHMRI and Flinders University has found a link between the type of microbiome that repopulates the gut following antibiotics and shortened lifespan in mice.

Maybe.


To combat this issue, Astroscale Inc., a private Japan-headquartered company, has devised several commercial spacecrafts tasked with decluttering space. The company is on track to deliver the world’s first garbage truck for removing defunct satellites in 2,024 and today announced its prototype completed its first demonstration in space. Although experts say that one active debris remover isn’t enough to solve the problem, it is an important move toward protecting valuable equipment in space, including satellites that aid with everything from weather forecasts to GPS navigation.

“Those services are under threat,” says Lewis. “That threat is the destruction of the satellites, or the disruption to the services because we have to maneuver the satellites to avoid the space debris.”